Drug repurposing for the treatment of Type 2 Diabetes and Gestational Diabetes Mellitus

Abstract

Currently, repurposing an existing medicine for treatment of a different disease is a good and lucrative choice because of the long and time-consuming research and development process of new drugs and the high attrition rate. The utilization of low-risk chemicals, lower overall research costs, and shorter development timelines are all contributing to its growth and appeal. Ideal repurposed medication candidates have been found using a variety of date- and experimental-driven methodologies. However, there are a number of technological and legislative issues that must be addressed. Type 2 and gestational diabetes mellitus are both forms of diabetes mellitus, although gestational diabetes mellitus is a transitory condition that can lead to type 2 diabetes in the future. About 90% to 95% of diabetic people have type 2 diabetes, which is the most common form of the disease. Currently medications used for the treatment of these two diabetes is basically Metformin which often regarded as first line of treatment for Diabetes, but it is not affective too much and just control the condition. In order to identify a more effective therapy for Type 2 diabetes and gestational diabetes, we are going to use the Drug repurposing approach to look at novel pharmaceuticals and treatments and alternative combinations of current drugs. Medicine repurposing strategies and their usage in the search for a better drug or combination of drugs for the treatment of Type 2 Diabetes and Gestational Diabetes have been addressed in this review article.